Results 91 to 100 of about 35,727 (251)

The Effect of Moderate Dietary Protein and Phosphate Restriction on Calcium-Phosphate Homeostasis in Healthy Older Cats [PDF]

, 2016
Background Dietary phosphate and protein restriction decreases plasma PTH and FGF‐23 concentrations and improves survival time in azotemic cats, but has not been examined in cats that are not azotemic.
Antoniucci, Backlund, Barber, Barber, Berndt, Brown, Burnett, Dong, Elliott, Ferrari, Finch, Finch, Finch, Freeman, Geddes, Geddes, Greene, Hall, Hoek, Hutchins-Wiese, Isakova, Isakova, Isakova, Jepson, Jepson, Jepson, Jepson, Kamycheva, Kumar, Laflamme, Larsson, Lulich, Marino, Moe, Muntner, Nishida, NRC, Paepe, Parker, Pineda, Reynolds, Ross, Saito, Schulz, Shipov, Sigrist, Spatz, Trivedi, Wakeling, Wakeling, Williams, Zhang   +51 more
core   +3 more sources

A Comprehensive Review on Nutrition, Phytochemistry, Pharmacology and Food Application Perspectives of Bioactive Rich Superfruits

Future Postharvest and Food, EarlyView.
The review critically evaluated and compared the selected superfruit phytochemistry, their bioactive composition and the key health benefits majorly emphasizing the antioxidant potential. It has highlighted the translational challenges in formulating functional foods by addressing the issues related to delivery system, bioavailability mechanism and the
Sharath Kumar Nagaraja, Javid Iqbal Mir, Mahendra Kumar Verma, Aamir Hussain Dar   +3 more
wiley   +1 more source

The connections between vascular calcification and bone health [PDF]

, 2013
Vascular calcification, bone loss and increased fracture risk are age-associated disorders. Several epidemiological studies have suggested a relationship between vascular calcification, impaired bone metabolism and increased mortality.
Cannata, J.B. (Jorge), Hruska, Keith, Román-García, Pablo   +2 more
core  

Harnessing Free Radical Scavenging Potential of Caffeic Acid as a Nutraceutical—A Review

Food Safety and Health, EarlyView.
Caffeic acid has emerged as a promising bioactive molecule with multiple pharmacological properties, including antioxidant, antimicrobial, anti‐inflammatory, organ protective properties and metal‐chelating ability. This review emphasizes the dietary sources, structural characteristic, molecular mechanism underlying health promoting effects of caffeic ...
Pavitra Behra, Monika Bhadauria, Satendra Kumar Nirala   +2 more
wiley   +1 more source

Uremic lion face syndrome

Brazilian Journal of Nephrology, 2019
Mineral bone disorder is a common feature of chronic kidney disease. Lion face syndrome is rare complication of severe hyperparathyroidism in end-stage renal disease patients, which has been less commonly reported due to dialysis and medical treatment ...
Joana Gameiro, Inês Duarte, Cristina Outerelo, José António Lopes   +3 more
doaj   +1 more source

Which Outcome in Chronic Kidney Disease-Mineral and Bone Disorder Patients? [PDF]

Nephro-Urology Monthly, 2014
Dear Editor, Secondary hyperparathyroidism (SHPT) is one the major complications in dialysis patients. Hyperphosphatemia, hypocalcemia, low serum vitamin D levels are greatly involved into the physiopathology of SHPT in chronic kidney disease (CKD), in which the down-regulation of parathyroid Vitamin D Receptor (VDR) and Calcium Sensing Receptor ...
openaire   +3 more sources

Sotatercept safety and effects on hemoglobin, bone, and vascular calcification [PDF]

, 2019
Introduction: Patients with end-stage kidney disease (ESKD) exhibit anemia, chronic kidney disease‒mineral bone disorder (CKD-MBD), and cardiovascular disease.
Connarn, Jamie N, Coyne, Daniel W, Dellanna, Frank, Giuseppi, Ana Carolina, Hruska, Keith A, Malluche, Hartmut H, Sherman, Matthew L, Singh, Hem N, Smith, William T   +8 more
core   +1 more source

Pharmacological Management of Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease [PDF]

, 2016
Secondary hyperparathyroidism (SHPT) is a common complication of CKD and is part of the chronic kidney disease-mineral bone disorder (CKD-MBD). SHPT is associated with increased risk of fracture and mortality, thus SHPT control is recommended as kidney ...
Khwaja, A., Salam, S.N., Wilkie, M.E.
core   +1 more source

Construction of Chronic Kidney Disease Mouse Model Induced by Diets With Different Adenine Content

Food Safety and Health, EarlyView.
By administering a 4 weeks adenine diet to C57BL/6J mice, we identified 0.2% adenine in purified feed as the optimal chronic kidney disease model. This model induces severe renal damage, gut dysbiosis, uremic toxin accumulation, and CKD mineral bone disorder, providing a clinically relevant platform for mechanistic and therapeutic studies.
Wanjun Liao, Jiayao Wang, Yilian Huang, Na Zhang, Xiaodan Shi, Zongcai Tu, Zuohua Xie, Tao Yuan, Hongmei Yin   +8 more
wiley   +1 more source

Current therapeutic approach of chronic kidney disease‐mineral and bone disorder

Therapeutic Apheresis and Dialysis
AbstractChronic kidney disease (CKD) has emerged as one of the leading noncommunicable diseases affecting >10% of the population worldwide. Bone and mineral disorders are a common complication among patients with CKD resulting in a poor life quality, high fracture risk, increased morbidity and cardiovascular mortality.
Maria Zaimi, Eirini Grapsa
openaire   +3 more sources